Philips and Spanish Healthcare Group Vithas Sign Strategic Agreement

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Vithas Group, Spain's second largest private healthcare group, signed a 5-year innovation and collaboration agreement in the areas of precision diagnosis and image-guided intervention. The agreement will allow Vithas Group hospitals and medical centers to benefit from the latest innovations in diagnostic imaging technology, healthcare informatics, and equipment for minimally-invasive interventional procedures. Vithas Group hospitals and clinics offer healthcare and advanced medical care in thirteen provinces in seven autonomous regions of Spain.

Under the terms of the agreement, Philips will deliver a technology management model that ensures Vithas Group's current and future health technology needs in the relevant areas are met, together with the associated maintenance, updating, and equipment and system renewal needs. This management model will enable Vithas Group to achieve better results, provide optimal care at lower cost, and deliver a better experience for its patients and healthcare professionals.

In addition, Vithas will become a ‘reference technology partner’ for Philips in Spain, which means that its hospitals and medical centers will be able to implement new advances and innovations developed by Philips, before standard commercialization of these solutions in Spain.

"This new alliance with Philips integrates cutting-edge technology, healthcare excellence, innovation, and research, which are the fundamental pillars on which we support our commitment to always seek the best experience for our patients," said Dr. Pedro Rico, CEO of Vithas Group. "Furthermore, our professionals will have the most advanced technological solutions at all times, which will reinforce the quality of care and facilitate their research work."

"We are very excited about the trust placed in Philips and convinced that, through this collaboration agreement, Vithas will have all the technology and innovation necessary to continue achieving the best health results and the best experience for its patients and its healthcare professionals," said Juan Sanabria, President of Philips Ibérica. "We are proud to become the technological partner and strategic ally of a group as important as Vithas."

The most advanced diagnostic imaging technology

The agreement includes the replacement of Vithas Group's existing MR imaging equipment with Philips' latest innovative MR systems, which stand out for their image quality and patient comfort, and because they do not consume helium, also stand out for their sustainability. Philips will also install hybrid operating room solutions, including its latest ceiling mounted live-image guidance system for minimally-invasive interventional therapy, allowing Vithas hospitals to perform many types of procedure with maximum precision and safety. Four new hybrid operating rooms will be installed across four of the group's hospitals.

Next to this, Philips will replace the Vithas hospitals’ CT (Computed Tomography) equipment by high-end equipment, allowing them to perform more precise cardiac diagnoses thanks to the Philips equipment's speed, coverage, and high image quality, while also minimizing radiation dose. The agreement also includes X-ray equipment, solutions for dose management, and a Corporate Network for Diagnostic Imaging.

Benefits of the Corporate Network for Diagnostic Imaging

Through this network, and thanks to a solution for reviewing, post-processing and sharing information from advanced medical imaging studies, more than 100 radiologists will be able to work in a unified way with access to tools that speed up and improve the quality of results. Likewise, more than 5,000 referring physicians will have higher quality radiological reports directly available to them via a clinical viewer. The solution will also improve the patient experience, because they will be able to view their reports and images from any PC or mobile device via a secure web portal.

Joint scientific research

The innovation and collaboration agreement between Philips and Vithas Group will make it possible for the two organizations to collaborate in technological innovation projects in Vithas Group reference centers. These projects will involve joint scientific research in key healthcare areas, as well as the training of Vithas Group professionals in new technologies and clinical procedures.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries.

About Vithas Group

Vithas' commitment: accredited healthcare quality, personal service and long-term vision.

Vithas' strategic commitment is that all healthcare is endorsed by the standards of the most prestigious international quality accreditation, the Joint Commission International. Only 15 prestigious hospitals in Spain have such accreditation and recognition, and three of them are part of Vithas, in Madrid, Malaga and Granada. Every year Vithas treats more than 5,200,000 patients in its 19 hospitals and 21 Vithas Salud medical centers. The 40 centers are located throughout Spain and include hospitals in Alicante, Almería, Benalmádena, Castellón, Granada, Las Palmas de Gran Canaria, Lleida, Madrid, Málaga, Seville, Tenerife, Vigo, Valencia and Vitoria-Gasteiz. The 26 Vithas Salud centers are located in Alicante, Elche, El Ejido, Fuengirola, Granada, Las Palmas de Gran Canaria, Lleida, Madrid, Malaga, Nerja, Pontevedra, Rincón de la Victoria, Sanxenxo, Seville, Torre del Mar, Torremolinos, Vilagarcía de Arousa, and Vitoria-Gasteiz. Additionally, Vithas has more than 300 locations throughout Spain as part of the Vithas Lab laboratories network. Its PlazaSalud24 purchasing center, a benchmark in the sector, serves 39 hospitals, 35 medical centers and 20 dental clinics.

Vithas has a stake in the leading hospital project in the Balearic Islands, the Juaneda Healthcare Network, which has 5 hospitals and a wide network of medical centers throughout the region.

Vithas' commitment to proven quality healthcare and personalized service goes hand in hand with the strong support and long-term vision of Vithas' shareholders: Goodgrower, which controls 80% of the capital, and CriteriaCaixa, with the remaining 20%.

With a growth model based on geographic diversification and sustainability, Vithas plans to continue consolidating its national presence both by opening new centers and through acquisitions and strategic agreements.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...